Previously approved for IV infusion.
Reduces risk for heart failure and cardiovascular disease hospitalizations.
Now approved for risk reductions in patients with type 2 diabetes mellitus.
How the first oral GLP-1 oral treatment for type 2 diabetes is unique and how it will be priced compared to other GLP-1 medications.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
FDA granted Fast Track designation to a popular diabetes drug to reduce the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.
FDA fast-tracks biosimiliar insulin products to elevate competition.
To stave off competition from other generic makers and appease Congress, Eli Lilly is introducing a generic version of its insulin lispro injection (Humalog).
FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.
While FDA has approved other continuous glucose monitoring (CGM) systems, it just approved the first system that includes a fully implantable sensor to detect glucose.